These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6412759)

  • 1. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I; Buchmann MS; Skrede S
    Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
    J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
    Skrede S; Bjørkhem I
    Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
    Buchmann MS; Björkhem I; Lund AM; Skrede S
    Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
    J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic 7 alpha-dehydroxylation of bile acid intermediates, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
    Skrede S; Buchmann MS; Björkhem I
    J Lipid Res; 1988 Feb; 29(2):157-64. PubMed ID: 3367085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
    Salen G; Polito A
    J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
    Björkhem I; Skrede S; Buchmann MS; East C; Grundy S
    Hepatology; 1987; 7(2):266-71. PubMed ID: 3557306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of intermediates in bile acid biosynthesis using isotope dilution--mass spectrometry: hepatic levels in the normal state and in cerebrotendinous xanthomatosis.
    Björkhem I; Oftebro H; Skrede S; Pedersen JI
    J Lipid Res; 1981 Feb; 22(2):191-200. PubMed ID: 7017048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of cholestanol from intestinal 7 alpha-hydroxy-4-cholesten-3-one.
    Skrede S; Björkhem I
    J Biol Chem; 1982 Jul; 257(14):8363-7. PubMed ID: 7045120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Grundy SM
    J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
    Björkhem I; Hansson M
    Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the mechanism of the increased biosynthesis of cholestanol in cerebrotendinous xanthomatosis. The activity of delta 5-3 beta-hydroxysteroid dehydrogenase.
    Buchmann MS; Björkhem I; Fausa O; Skrede S
    Scand J Gastroenterol; 1985 Dec; 20(10):1262-6. PubMed ID: 3868019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of cholestanol from bile acid intermediates in the rabbit and the rat.
    Skrede S; Björkhem I; Buchmann MS; Midtvedt T
    J Biol Chem; 1985 Jan; 260(1):77-81. PubMed ID: 3917436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
    J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors.
    Oftebro H; Björkhem I; Størmer FC; Pedersen JI
    J Lipid Res; 1981 May; 22(4):632-40. PubMed ID: 6792308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation.
    Norlin M; von Bahr S; Bjorkhem I; Wikvall K
    J Lipid Res; 2003 Aug; 44(8):1515-22. PubMed ID: 12777473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
    J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.